CJC No DAC + Impamorelin

CJC No DAC + Ipamorelin – Research Grade Peptides

CJC No DAC + Ipamorelin is a combination of synthetic peptides supplied exclusively for laboratory research and analytical purposes. These compounds are commonly studied together in controlled research environments for their interaction with growth hormone–related signalling pathways.

This product is classified as an unlicensed investigational combination and has not been authorised for use as a medicinal product in the United Kingdom by the Medicines and Healthcare products Regulatory Agency (MHRA) or any other regulatory authority.

Research Context

CJC No DAC and Ipamorelin are typically investigated in relation to:

• Growth hormone–releasing hormone (GHRH) receptor activity

• Ghrelin receptor (GHSR) interactions

• Peptide signalling and endocrine pathway models

These areas remain under ongoing scientific investigation. Any references are provided for informational purposes only and do not represent established clinical outcomes.

Intended Use

• For in vitro research use only

• Not for human or veterinary use

• Not intended for medicinal, diagnostic, or therapeutic purposes

This product must only be handled by qualified professionals within appropriate laboratory environments.

Regulatory Compliance

This product is not a licensed medicine and must not be marketed, sold, or used as such. It is supplied strictly on the condition that it will be used for legitimate research purposes only.

Disclaimer

All information provided is for educational and scientific purposes only. No claims are made regarding safety, efficacy, or suitability for any medical application. The supplier does not promote or condone use outside of controlled research settings.